Shijiazhuang Puli Pharmaceutical

Shijiazhuang Puli Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical company and a key subsidiary of Hainan Puli Pharmaceutical. The company specializes in the research, development, and large-scale manufacturing of high-end generic drugs, Active Pharmaceutical Ingredients (APIs), and complex injectable formulations. Its core product portfolio includes medical imaging contrast agents such as Iopamidol and Iohexol, as well as anti-infective and cardiovascular medications. Shijiazhuang Puli operates state-of-the-art facilities that comply with international GMP standards, enabling the group to export products to highly regulated markets including the United States and the European Union. The company plays a vital role in the global supply chain for essential generic medicines and continues to expand its pipeline with value-added pharmaceutical products.